ABUS

#2561
Arbutus Biopharma Corporation Common Stock
4.35 USD
-0.46%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
4.35
4.35
Rango anual
2.94
5.10
Cambio diario
-0.46%
Variación mensual
+1.16%
Variación en los últimos 6 meses
+2.59%
Cambio anual
+32.62%
Cierres anteriores
4.37
Abrir
4.35
Bid
Ask
Mínimo
4.35
High
4.35
Volumen
83
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 850.33 M
  • Employee 19
  • Founded 2007
  • CEO William H. Collier
  • Website www.arbutusbio.com
  • Headquarter British Columbia, Canada
  • FIGI BBG000RR8V85
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-28.29
Relación precio/flujo de caja
65.44

Arbutus Biopharma Corporation

Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007.

Noticias